3 Reasons Boston Scientific Stock Could Quietly 5X as the World Ages

Earth's human population is aging. According to recent research from the World Health Organization, from 2015 to 2050, the proportion of people 60 or older will almost double, from 12% of the total to 22%. That's a big leap over a relatively short period, and the trend offers a significant opportunity for medical device makers, especially Boston Scientific (NYSE: BSX). Here are three reasons why its stock can quintuple -- at least -- on the back of this shift. Boston Scientific's focus on afflictions that affect older patients is nothing new. Its Watchman line, which debuted in 2015, consists of small balloon-expandable heart inserts that reduce stroke risk in those with a type of atrial fibrillation (a disorder that skews toward the elderly). Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool